Showing results (281-290 of 295) with videos related to
Sort By:
Pageof 30
ESMO Open|August 3, 2024
Nomogram for predicting survival after first-line anti-PD-1-based immunotherapy in unresectable stage IV melanoma: a multicenter international studyE Chatziioannou, L M Serna Higuita, S Kreft, et al.The FEBS Journal|June 23, 2015
Delineating transcriptional networks of prognostic gene signatures refines treatment recommendations for lymph node-negative breast cancer patientsFiona Lanigan, Gerard L Brien, Yue Fan, et al.The British Journal of Dermatology|January 17, 2021
A multicentre study of naevus-associated melanoma vs. de novo melanoma, tumour thickness and body site differencesC Dessinioti, A C Geller, A Stergiopoulou, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|April 12, 2023
Cutaneous manifestations induced by check point inhibitors in 120 melanoma patients-The European MelSkinTox studyJ-M L'Orphelin, J Cassecuel, L Kandolf, et al.ESMO Open|May 9, 2025
Early switch from run-in with targeted to immunotherapy in advanced BRAFV600-positive melanoma: final results of the randomised phase II ImmunoCobiVem trialE Livingstone, H J Gogas, L Kandolf, et al.European Journal of Cancer (Oxford, England : 1990)|July 23, 2023
Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trialE Livingstone, H Gogas, L Kandolf-Sekulovic, et al.European Journal of Cancer (Oxford, England : 1990)|December 25, 2024
An update on access to novel treatment for metastatic melanoma in Europe - A 2024 survey of the European melanoma registry and the European association of dermato-oncologyL Kandolf, P A Ascierto, L Bastholt, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 6, 2017
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 studyG V Long, K T Flaherty, D Stroyakovskiy, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|December 16, 2020
Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countriesL Kandolf-Sekulovic, K Peris, A Stratigos, et al.European Journal of Cancer (Oxford, England : 1990)|November 3, 2018
Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countriesL Kandolf Sekulovic, J Guo, S Agarwala, et al.Pageof 30